Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Benjamin Hohl > Profile

Benjamin Hohl

Affiliations

  • Chief Financial Officer at Enliven Therapeutics Inc. (ELVN), 2025-03-31
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Enliven Therapeutics Inc.
 ELVN $21.33 3,250 23,000 2025-03-27 Filing
Enliven Therapeutics Inc.
 ELVN $22.50 1,000 23,000 2025-03-24 Filing
Enliven Therapeutics Inc.
 ELVN $20.41 3,250 13,000 2025-02-27 Filing
Enliven Therapeutics Inc.
 ELVN $22.52 1,000 13,000 2025-02-05 Filing
Enliven Therapeutics Inc.
 ELVN $21.59 3,250 13,000 2025-01-27 Filing